For research use only
| Cat No. | ABC-SC201Y |
| Product Type | Human Induced Pluripotent Stem Cells derived |
| Cell Type | Ventricular Cardiomyocyte |
| Species | Human |
| Growth Conditions | 37 °C, 5% CO₂ |
| Source Organ | Heart |
| Disease | Normal |
| Storage | Liquid Nitrogen |
HighQC™ Human iPSC-Derived Ventricular Cardiomyocytes (Male) give you reliable, ready-to-use cells for strong heart research and drug testing.
Human iPSC-Derived Ventricular Cardiomyocytes are generated from induced pluripotent stem cells, typically reprogrammed from somatic cells such as pulmonary fibroblasts (e.g., from a male donor). These cells express key cardiac markers, including ventricular-specific myosin heavy chain 7 (MYH7), cardiac troponin T (TNNT2), and troponin I (cTnI). Functionally, they display spontaneous beating, generate ventricular-like action potentials, and show excitation-contraction coupling, although with electrophysiological immaturity compared to adult cardiomyocytes. When combined with disease-specific interventions, these cells serve as models for studying cardiac pathologies such as arrhythmias, contractile dysfunction, or drug-induced cardiotoxicity.
| Species | Human |
| Cat.No | ABC-SC201Y |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Ventricular Cardiomyocyte |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO₂ |
| Source Organ | Heart |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Induced Pluripotent Stem Cells derived |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
HighQC™ Human iPSC-Derived Ventricular Cardiomyocytes (Male) can be used as an ideal in vitro model to evaluate the potential toxicity of drugs to the heart and screen out drugs that may cause adverse reactions such as arrhythmias and myocardial damage in advance. In addition, the cells can also be used in cardiac regenerative medicine research, providing a basis for the development of cell-based cardiac repair strategies.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).